AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15969319 — intervention group
Group type: EXPERIMENTAL
Intervention: Loprin (test product)
Number of subjects: 16
Study 12638032 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytosterol-enriched spread (2 x 10 g daily)
Number of subjects: 85
Study 12638032 — intervention group
Group type: COMPARATOR
Intervention: Placebo spread
Number of subjects: 85
Study 10576398 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned group receiving an 8‐s 70‐db tone paired with a 500‐ms electric shock in a delay conditioning paradigm.
Number of subjects: 0
Study 10576398 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving the CS and UCS on a truly random schedule.
Number of subjects: 0
Study 7749448 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual compression with a pressure dressing
Number of subjects: 503
Study 7749448 — intervention group
Group type: COMPARATOR
Intervention: Mechanical compression with a pressure dressing
Number of subjects: 503
Study 7749448 — intervention group
Group type: COMPARATOR
Intervention: Crossover from mechanical to manual compression
Number of subjects: 503
Study 2102123 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracranial-intracranial bypass surgery
Number of subjects: 1464
Study 2102123 — intervention group
Group type: COMPARATOR
Intervention: Controlled clinical trial (medical treatment)
Number of subjects: 1464
Study 380456 — intervention group
Group type: EXPERIMENTAL
Intervention: Monomycin with a diet with an excessive protein content (25% higher than the physiological norm)
Number of subjects: 80
Study 380456 — intervention group
Group type: COMPARATOR
Intervention: Control groups (60 children, 3 groups of 20 each) without excessive protein diet
Number of subjects: 80
Study 31947884 — intervention group
Group type: EXPERIMENTAL
Intervention: Play-based intervention (physical activity, play, and nutritional advice)
Number of subjects: 49
Study 31947884 — intervention group
Group type: COMPARATOR
Intervention: Nutritional advice only (control group)
Number of subjects: 49
Study 30641691 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride 2 mg twice daily + l-carnitine 1 g twice daily
Number of subjects: 58
Study 30641691 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride 2 mg twice daily
Number of subjects: 58
Study 28434269 — intervention group
Group type: EXPERIMENTAL
Intervention: Device with reminder features enabled
Number of subjects: 1306
Study 28434269 — intervention group
Group type: COMPARATOR
Intervention: Device with reminder features disabled
Number of subjects: 1306
Study 28434269 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1306
Study 25487638 — intervention group
Group type: EXPERIMENTAL
Intervention: Achilles tendon taps
Number of subjects: 6
Study 25487638 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsiflexion stretches
Number of subjects: 6
Study 23274601 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI, 8°C)
Number of subjects: 9
Study 23274601 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT, seated in normal ambient conditions)
Number of subjects: 9
Study 23274601 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI)
Number of subjects: 9
Study 23274601 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 9
Study 21866652 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM)
Number of subjects: 91
Study 21866652 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 91
Study 21866652 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Chinese medicine and chemotherapy
Number of subjects: 91
Study 19519904 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time educational intervention (40-minute session)
Number of subjects: 660
Study 19519904 — intervention group
Group type: EXPERIMENTAL
Intervention: Teach-to-goal educational intervention (40-minute session + 20 minutes of additional education + periodic follow-up phone calls)
Number of subjects: 660
Study 19519904 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care after the initial education session)
Number of subjects: 660
Study 19519904 — intervention group
Group type: COMPARATOR
Intervention: Both groups (initial education session)
Number of subjects: 660
Study 17145735 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 108
Study 17145735 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 108
Study 17145735 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 108
Study 14971963 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking program (3 times per week, low-endurance walking at 0% incline)
Number of subjects: 14
Study 14971963 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking program
Number of subjects: 14
Study 14971963 — intervention group
Group type: COMPARATOR
Intervention: Control group (nontreadmill, n = 12)
Number of subjects: 14
Study 11699024 — intervention group
Group type: EXPERIMENTAL
Intervention: Transport Thermal Mattress (TTM)
Number of subjects: 191
Study 11699024 — intervention group
Group type: COMPARATOR
Intervention: No Mattress
Number of subjects: 191
Study 9029226 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity training (80% maximal O2 uptake)
Number of subjects: 26
Study 9029226 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity training (50% maximal O2 uptake)
Number of subjects: 26
Study 7953034 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive aftercare by community psychiatric nurse (CPN) team with a case management approach (n = 52 contacts)
Number of subjects: 82
Study 7953034 — intervention group
Group type: COMPARATOR
Intervention: Generic care by community psychiatric nurse (CPN) team (n = 13 contacts)
Number of subjects: 82
Study 3311432 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (12.5 mg) with ketamine (250 mg)
Number of subjects: 50
Study 3311432 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (20 mg) with ketamine (250 mg)
Number of subjects: 50
Study 31645162 — intervention group
Group type: EXPERIMENTAL
Intervention: SGA
Number of subjects: 2315
Study 31645162 — intervention group
Group type: COMPARATOR
Intervention: AGA
Number of subjects: 2315
Study 29914924 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cephalexin 500 mg four times daily
Number of subjects: 206
Study 29914924 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cefazolin 2 g daily plus oral probenecid 1 g daily
Number of subjects: 206
Study 26954311 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast
Number of subjects: 0
Study 26954311 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast (30 mg twice weekly)
Number of subjects: 0
Study 24992187 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training group
Number of subjects: 119
Study 24992187 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 119
Study 24992187 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 119
Study 23740633 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (8 weeks duration, consisting of stretching, muscle strength training, balance training, and toe stretching)
Number of subjects: 196
Study 23740633 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 196
Study 20209170 — intervention group
Group type: COMPARATOR
Intervention: Standard Transbond primer (Control group)
Number of subjects: 120
Study 20209170 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride‐releasing primer (Reliance fluoride containing light cure bond)
Number of subjects: 120
Study 20209170 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial fluoride‐releasing self‐etching primer (Clearfil Protect Bond)
Number of subjects: 120
Study 18414108 — intervention group
Group type: EXPERIMENTAL
Intervention: Travoprost ophthalmic solution 0.004% (BAK-free)
Number of subjects: 109
Study 18414108 — intervention group
Group type: COMPARATOR
Intervention: Travoprost ophthalmic solution 0.004% (with BAK)
Number of subjects: 109
Study 16828939 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination (2004/2005 influenza vaccine)
Number of subjects: 104
Study 16828939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 12811363 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (1200 mg/d)
Number of subjects: 10
Study 12811363 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 11341181 — intervention group
Group type: EXPERIMENTAL
Intervention: Histoacryl (H)
Number of subjects: 157
Study 11341181 — intervention group
Group type: COMPARATOR
Intervention: Dermabond (D)
Number of subjects: 157
Study 11341181 — intervention group
Group type: EXPERIMENTAL
Intervention: Histoacryl (H) and Dermabond (D)
Number of subjects: 157
Study 8629722 — intervention group
Group type: EXPERIMENTAL
Intervention: Assured treatment design
Number of subjects: 0
Study 8629722 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 1596224 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 centistokes of silicone oil
Number of subjects: 101
Study 1596224 — intervention group
Group type: COMPARATOR
Intervention: 20% sulfur hexafluoride gas and air
Number of subjects: 101
Study 6397333 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 200 mg to 400 mg daily
Number of subjects: 50
Study 6397333 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam 20 mg to 40 mg daily
Number of subjects: 50
Study 30442550 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-sized particles (0.25-1mm)
Number of subjects: 10
Study 30442550 — intervention group
Group type: COMPARATOR
Intervention: Large-sized particles (1-2mm)
Number of subjects: 10
Study 28452829 — intervention group
Group type: EXPERIMENTAL
Intervention: BTrackS Balance Test on days 1, 3, 8, and 15
Number of subjects: 20
Study 26135853 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (25 mg)
Number of subjects: 48
Study 26135853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 25428433 — intervention group
Group type: EXPERIMENTAL
Intervention: OPT program plus usual care
Number of subjects: 4730
Study 25428433 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 4730
Study 25428433 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 4730
Study 22155448 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 23
Study 22155448 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq
Number of subjects: 23
Study 22155448 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax AirwayScope
Number of subjects: 23
Study 22155448 — intervention group
Group type: EXPERIMENTAL
Intervention: Storz C‐MAC
Number of subjects: 23
Study 22155448 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath Series5
Number of subjects: 23
Study 22155448 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope Ranger
Number of subjects: 23
Study 22155448 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope, Airtraq, Storz C‐MAC
Number of subjects: 23
Study 22155448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu Pentax AWS, Glidescope Ranger
Number of subjects: 23
Study 19995412 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmentally tailored intervention
Number of subjects: 1971
Study 19995412 — intervention group
Group type: COMPARATOR
Intervention: Basic tailored intervention
Number of subjects: 1971
Study 17446985 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise during testing sessions
Number of subjects: 78
Study 15162273 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification technique
Number of subjects: 94
Study 15162273 — intervention group
Group type: COMPARATOR
Intervention: Extracapsular cataract extraction
Number of subjects: 94
Study 11593107 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg once daily
Number of subjects: 13
Study 11593107 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan 150 mg once daily
Number of subjects: 13
Study 11593107 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg b.i.d.
Number of subjects: 13
Study 9704709 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim 5 microg/kg plus SCF (doses of 5, 10, 15, and 20 microg/kg)
Number of subjects: 48
Study 9704709 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim 5 microg/kg alone
Number of subjects: 48
Study 7989631 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis before injection
Number of subjects: 29
Study 7989631 — intervention group
Group type: COMPARATOR
Intervention: No hypnosis (control)
Number of subjects: 29
Study 2722725 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefmetazole (2 g single dose administered IV within 90 min of operation)
Number of subjects: 195
Study 2722725 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin (2 g single dose preoperative and two additional doses at 6 h intervals post-surgery)
Number of subjects: 195
Study 30071525 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet II - low fat diet
Number of subjects: 239
Study 30071525 — intervention group
Group type: COMPARATOR
Intervention: Diet I - high fat diet
Number of subjects: 239
Study 26501700 — intervention group
Group type: EXPERIMENTAL
Intervention: GLN-supplemented parenteral nutrition (GLN-PN)
Number of subjects: 150
Study 26501700 — intervention group
Group type: COMPARATOR
Intervention: Standard GLN-free parenteral nutrition (STD-PN)
Number of subjects: 150
Study 26501700 — intervention group
Group type: EXPERIMENTAL
Intervention: GLN-PN
Number of subjects: 150
Study 26501700 — intervention group
Group type: COMPARATOR
Intervention: STD-PN
Number of subjects: 150
Study 25657064 — intervention group
Group type: EXPERIMENTAL
Intervention: LCZ696
Number of subjects: 301
Study 25657064 — intervention group
Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 301
Study 23689261 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 5 mg
Number of subjects: 349
Study 23689261 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg
Number of subjects: 349
Study 23689261 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 349
Study 23689261 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-experienced infants
Number of subjects: 349
Study 23689261 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-naïve infants
Number of subjects: 349
Study 20862932 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment at Renying (ST 9), Fengfu (GV 16), Baihui (GV 20)
Number of subjects: 90
Study 20862932 — intervention group
Group type: COMPARATOR
Intervention: Shenmai injection combined with 250 mL 5% Glucose injection
Number of subjects: 90
Study 18795987 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 74
Study 18795987 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 16262971 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran
Number of subjects: 0
Study 12564351 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-minute back massage
Number of subjects: 46
Study 10370789 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum drug treatment
Number of subjects: 46
Study 8683652 — intervention group
Group type: EXPERIMENTAL
Intervention: Maneuver A
Number of subjects: 0
Study 8683652 — intervention group
Group type: EXPERIMENTAL
Intervention: Maneuver B
Number of subjects: 0
Study 8683652 — intervention group
Group type: COMPARATOR
Intervention: Post-treatment instructions
Number of subjects: 0
Study 1761494 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion (15 degrees C)
Number of subjects: 0
Study 1761494 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body exposure (15 degrees C)
Number of subjects: 0
Study 1761494 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper torso exposure (15 degrees C)
Number of subjects: 0
Study 1761494 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower torso exposure (15 degrees C)
Number of subjects: 0
Study 1761494 — intervention group
Group type: COMPARATOR
Intervention: Control immersion (34 degrees C)
Number of subjects: 0
Study 7052117 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine regular antenatal cardiotocography (CTG)
Number of subjects: 353
Study 7052117 — intervention group
Group type: COMPARATOR
Intervention: Concealed CTG tracings
Number of subjects: 353
Study 7052117 — intervention group
Group type: COMPARATOR
Intervention: Revealed CTG tracings
Number of subjects: 353
Study 31155298 — intervention group
Group type: EXPERIMENTAL
Intervention: Regenerative endodontic procedures (REPs)
Number of subjects: 56
Study 31155298 — intervention group
Group type: COMPARATOR
Intervention: Conventional root canal treatment (CRCT)
Number of subjects: 56
Study 27311651 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Web‐based decision support tool
Number of subjects: 0
Study 27311651 — intervention group
Group type: COMPARATOR
Intervention: Educational pamphlet (control)
Number of subjects: 0
Study 26025328 — intervention group
Group type: EXPERIMENTAL
Intervention: 480 mg choline/day
Number of subjects: 49
Study 26025328 — intervention group
Group type: EXPERIMENTAL
Intervention: 930 mg choline/day
Number of subjects: 49
Study 26025328 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specified choline intake)
Number of subjects: 49
Study 22826133 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial 1 (AIH): eight 4 min episodes of hypoxia
Number of subjects: 12
Study 22826133 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial 2 (ACH): continuous hypoxia for 32 min
Number of subjects: 12
Study 22826133 — intervention group
Group type: COMPARATOR
Intervention: Trial 3 (Control): euoxia throughout
Number of subjects: 12
Study 18948611 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 10101
Study 18948611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10101
Study 15743150 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy with external-beam radiation (EBRT)
Number of subjects: 0
Study 15743150 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy with brachytherapy
Number of subjects: 0
Study 15743150 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-pelvic EBRT and hormonal therapy
Number of subjects: 0
Study 15743150 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy with brachytherapy without pelvic radiotherapy
Number of subjects: 0
Study 12519868 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone
Number of subjects: 64
Study 12519868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 11228682 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail distributed evaluations
Number of subjects: 0
Study 11228682 — intervention group
Group type: COMPARATOR
Intervention: Mailed evaluations
Number of subjects: 0
Study 8780961 — intervention group
Group type: COMPARATOR
Intervention: Analog malingerers feigning deficits without task-specific instruction
Number of subjects: 3
Study 8780961 — intervention group
Group type: COMPARATOR
Intervention: Analog malingerers feigning deficits with task-specific instruction
Number of subjects: 3
Study 8780961 — intervention group
Group type: EXPERIMENTAL
Intervention: Analog malingerers
Number of subjects: 3
Study 8780961 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-report measures of postconcussive symptoms
Number of subjects: 3
Study 8780961 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical tests
Number of subjects: 3
Study 1995258 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (up to 20 mg)
Number of subjects: 8
Study 1995258 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (160 mg)
Number of subjects: 8
Study 1995258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 6437814 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nitroglycerin (TNG)
Number of subjects: 39
Study 6437814 — intervention group
Group type: COMPARATOR
Intervention: Control group (38 patients treated conventionally)
Number of subjects: 39
Study 31889177 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (rods and implants with DEAE-Dextran and Quil-A)
Number of subjects: 12
Study 31889177 — intervention group
Group type: COMPARATOR
Intervention: Group B (rods and implants with either DEAE-Dextran or Quil A)
Number of subjects: 12
Study 30698654 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs)
Number of subjects: 0
Study 30698654 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study 28190578 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadpill (irbesartan 37.5 mg, amlodipine 1.25 mg, hydrochlorothiazide 6.25 mg, atenolol 12.5 mg)
Number of subjects: 21
Study 28190578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 25403919 — intervention group
Group type: EXPERIMENTAL
Intervention: AG-PUFA (3 g/day for 8 weeks)
Number of subjects: 120
Study 25403919 — intervention group
Group type: EXPERIMENTAL
Intervention: EE-PUFA (3 g/day for 8 weeks)
Number of subjects: 120
Study 25403919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 24954344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine combined with intravenous patient-controlled analgesia (ITM-IVPCA)
Number of subjects: 64
Study 24954344 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled thoracic epidural analgesia (PCTEA)
Number of subjects: 64
Study 22882288 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive parenteral nutrition (PN) (amino acids 3 g/kg per day and lipids 2 g/kg per day on first day of life)
Number of subjects: 53
Study 22882288 — intervention group
Group type: COMPARATOR
Intervention: Conventional PN (amino acids 1.5 g/kg per day and lipids 1 g/kg per day on first day of life)
Number of subjects: 53
Study 19543114 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated formula (CF) 87 kcal/100 mL for 8 weeks
Number of subjects: 1998
Study 19543114 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF) 67 kcal/100 mL for 8 weeks
Number of subjects: 1998
Study 17265483 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg subcutaneously every other week)
Number of subjects: 151